Pharmalot... Pharmalittle... Good Morning

Good morning, folks, and apologies for the late start, but we encountered a tech problem this morning that delayed our usual opening. But that is all behind us now, which means we must get cracking. After all, this is shaping up to be an especially busy week and we trust that you relate. To cope, yes, we are downing cups of stimulation. Our flavor today is Cinnamon Hazelnut Creme, a special blend that we found in the wilds of Pennsylvania. Meanwhile, here are some tidbits. We wish you luck conquering the world today and, as always, remind you to stay in touch... Genzyme To Invest $80M In Fabrazyme Plant (Genetic Engineering News) Teva May Shift Some Israeli Plants To The Far East (Ha'aretz) AstraZeneca To Pay Up To $440M For Spirogen (Reuters) Savient Pharmaceuticals Files For Bankruptcy Protection (Bloomberg News) MannKind Files For FDA Approval Of Inhaled Insulin (Pharma Times) Eli Lilly Is A 'Least Preferred US Stock:' Analyst (Associated Press) Novartis Plant Workers To Get Federal Assistance (The Journal-Star) FDA...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs